drugset / Trial / NCT07434050

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy

NCT07434050

Phase 3 Recruiting 140 enrolled Hangzhou Sciwind Biosciences Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the study is to assess the efficacy and safety of XW003 injections in obese participants with OSA receiving PAP

Timeline

Start
2026-03-02
Primary completion
2028-06-19
Completion
2028-06-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Ecnoglutide Protein / enzyme biologic Subcutaneous